CUA Educational Content

Treatment Intensification across the Spectrum of Hormone Sensitive Disease

INVITED SPEAKER: KARIM FIZAZI

LEARNING OBJECTIVES:

At the conclusion of this program, participants should be able to:

  • Review latest advances in the research and how it will impact clinical practice
  • Discuss treatment intensification and duration – Who? When? How? What?
  • Assess optimal management of side effects
Start Quiz for Credits

ACCREDITATION

This activity is an Accredited Self-Assessment Program (Section 3) as defined by the Maintenance of Certification Program of the Royal College of Physicians and Surgeons of Canada, and approved by the Canadian Urological Association. You may claim a maximum of 1 hour of credit.

 

​This program was made possible with financial support from Abbvie and Bayer.

The Canadian Urological Association (CUA) does not provide professional medical advice, diagnosis or treatment and cannot respond to requests for direct feedback, specific patient information or physician referrals. You should first always seek the advice of your urologist, physician and other qualified health provider with any questions regarding your medical condition. The contents of the CUA Website such as text, graphics, images, and other content are for informational purposes only. The content/information is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Never disregard professional medical advice or delay in seeking it because of something you have read on the CUA website.

For comments or information, email Corporate.office@cua.org

Privacy Policy